mRNA-basierte Therapien für eine passive Immunisierung

The delivery of genetic information to enable the body to produce its own tailored medicine is a promising alternative to recombinant protein therapies. As such, the administration of mRNA offers a potent, flexible and apparently safe platform. Here we discuss the principles and perspectives of mRNA-based therapies focusing on its application in the field of passive immunization in general and for infectious diseases in particular.